Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9NZJ7

Entry ID Method Resolution Chain Position Source
AF-Q9NZJ7-F1 Predicted AlphaFoldDB

263 variants for Q9NZJ7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1049218663
CA137449749
2 G>A No ClinGen
TOPMed
gnomAD
rs746070892
CA3782673
3 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs1322996002
CA363848244
3 A>P No ClinGen
TOPMed
CA363848240
rs746070892
3 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs948192706
CA137449737
4 S>P No ClinGen
TOPMed
rs1246146125
CA363848225
6 P>A No ClinGen
TOPMed
gnomAD
rs959949185
CA137449720
6 P>R No ClinGen
Ensembl
rs1246146125
CA363848224
6 P>S No ClinGen
TOPMed
gnomAD
CA363848218
rs1327358435
7 E>V No ClinGen
TOPMed
CA363848209
rs1360410336
8 V>A No ClinGen
TOPMed
gnomAD
rs1360410336
CA363848208
8 V>G No ClinGen
TOPMed
gnomAD
rs1332158484
CA363848202
9 A>G No ClinGen
TOPMed
gnomAD
rs1332158484
CA363848203
9 A>V No ClinGen
TOPMed
gnomAD
CA137449713
rs1033982796
10 P>S No ClinGen
Ensembl
rs1187658042
CA363848183
12 A>D No ClinGen
TOPMed
rs1396970234
CA363848186
12 A>T No ClinGen
gnomAD
rs1187658042
CA363848181
12 A>V No ClinGen
TOPMed
CA363848179
rs1298900465
13 R>G No ClinGen
TOPMed
gnomAD
CA363848169
rs1388626266
14 G>V No ClinGen
gnomAD
rs963123343
CA137449647
15 G>C No ClinGen
TOPMed
gnomAD
rs202185562
CA137449645
16 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs564000422
CA3782670
16 A>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3782669
rs202185562
16 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 17 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1251706903
CA363848160
17 A>T No ClinGen
gnomAD
CA363848151
rs1203914895
18 G>E No ClinGen
gnomAD
rs1328296117
CA363848152
18 G>W No ClinGen
TOPMed
rs1481859943
CA363848140
19 M>I No ClinGen
gnomAD
CA363848134
rs1293552770
20 A>V No ClinGen
gnomAD
CA363848130
rs1427174492
21 G>E No ClinGen
gnomAD
CA363848122
rs1348812830
22 A>V No ClinGen
TOPMed
rs779583581
CA3782665
23 G>R No ClinGen
ExAC
gnomAD
rs1241110427
CA363848112
24 A>G No ClinGen
gnomAD
rs1241110427
CA363848111
24 A>V No ClinGen
gnomAD
rs1583272770
CA363848105
25 G>V No ClinGen
Ensembl
CA363848104
rs977375162
26 A>P No ClinGen
TOPMed
gnomAD
rs977375162
CA363848103
26 A>S No ClinGen
TOPMed
gnomAD
CA137449615
rs977375162
26 A>T No ClinGen
TOPMed
gnomAD
CA137449610
rs998357478
26 A>V No ClinGen
TOPMed
gnomAD
rs1305236329
CA363848097
27 G>E No ClinGen
TOPMed
gnomAD
CA363848099
rs1368926854
27 G>R No ClinGen
TOPMed
gnomAD
rs1583272727
CA363848094
28 A>T No ClinGen
Ensembl
rs1412335683
CA363848088
29 R>G No ClinGen
TOPMed
CA137449598
rs990012161
32 A>P No ClinGen
TOPMed
gnomAD
rs1471446243
CA363848066
32 A>V No ClinGen
gnomAD
CA137449596
rs1039675225
33 A>T No ClinGen
Ensembl
CA137449586
rs953310131
34 A>V No ClinGen
TOPMed
CA137449563
rs947337353
36 V>G No ClinGen
Ensembl
rs1368762939
CA363848048
36 V>L No ClinGen
TOPMed
rs1427152693
CA363848042
37 E>* No ClinGen
Ensembl
CA137449562
rs1043506956
39 R>* No ClinGen
gnomAD
rs1308794153
CA363848028
39 R>P No ClinGen
TOPMed
CA363848019
rs1199724312
41 R>G No ClinGen
TOPMed
gnomAD
rs1229335090
CA363848017
41 R>H No ClinGen
gnomAD
CA137449551
rs946171565
42 D>H No ClinGen
TOPMed
gnomAD
CA137449539
rs913017454
43 P>L No ClinGen
Ensembl
rs1206444410
CA363847998
44 P>L No ClinGen
TOPMed
gnomAD
rs1294346955
CA363847990
46 A>T No ClinGen
TOPMed
gnomAD
CA363847981
rs1233858882
47 H>P No ClinGen
TOPMed
rs561474203
CA137449522
48 R>H No ClinGen
1000Genomes
rs1273910007
CA363847967
49 A>V No ClinGen
TOPMed
CA137449517
rs541894384
50 H>L No ClinGen
1000Genomes
CA363847963
rs1351297416
50 H>Y No ClinGen
TOPMed
gnomAD
CA137449513
rs976102618
51 P>S No ClinGen
TOPMed
rs1267484277
CA363847953
52 R>S No ClinGen
gnomAD
CA3782662
rs767306901
53 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA363847937
rs762198203
54 P>H No ClinGen
ExAC
gnomAD
CA3782661
rs762198203
54 P>L No ClinGen
ExAC
gnomAD
rs1269871813
CA363847934
55 R>W No ClinGen
TOPMed
CA363847925
rs1405799185
56 P>L No ClinGen
gnomAD
CA363847923
rs1330530409
57 A>P No ClinGen
gnomAD
rs199897411
CA3782660
57 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA363847914
rs1386270822
58 A>V No ClinGen
gnomAD
rs552930498
CA3782659
60 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA363847888
rs1431919500
62 A>V No ClinGen
gnomAD
rs1176621307
CA363847882
63 R>H No ClinGen
gnomAD
rs1477488240
CA363847881
64 R>G No ClinGen
gnomAD
CA137449469
rs888050760
65 M>I No ClinGen
TOPMed
CA137449459
rs979748624
66 D>G No ClinGen
Ensembl
TCGA novel 67 G>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA137449448
rs1028299797
69 S>P No ClinGen
TOPMed
rs1194671656
CA363847840
70 G>E No ClinGen
gnomAD
CA137449440
rs1012421292
70 G>R No ClinGen
TOPMed
rs545428760
CA137449438
71 G>S No ClinGen
1000Genomes
TOPMed
gnomAD
rs1206771625
CA363847810
75 G>V No ClinGen
TOPMed
gnomAD
rs1362957806
CA363847807
76 D>Y No ClinGen
TOPMed
CA363847800
rs1325352365
77 N>D No ClinGen
gnomAD
rs578202903
CA3782658
78 A>T No ClinGen
1000Genomes
ExAC
gnomAD
CA363847786
rs1055587517
79 P>Q No ClinGen
TOPMed
rs1055587517
CA137449423
79 P>R No ClinGen
TOPMed
CA137449431
rs868404757
79 P>S No ClinGen
Ensembl
CA363847773
rs1273334679
81 T>I No ClinGen
gnomAD
rs1344550290
CA363847776
81 T>S No ClinGen
gnomAD
rs1266899975
CA363847760
83 A>G No ClinGen
TOPMed
rs1432923299
CA363847745
85 F>L No ClinGen
gnomAD
CA3782656
rs769819830
86 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs769819830
CA137449407
86 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1409027378
CA363847718
90 A>V No ClinGen
gnomAD
rs1177582446
CA363847714
91 G>D No ClinGen
gnomAD
TCGA novel 91 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363847687
rs1188343733
96 S>C No ClinGen
TOPMed
rs1041391575
CA137449386
99 L>V No ClinGen
TOPMed
CA137449384
rs867612249
100 L>I No ClinGen
Ensembl
rs747290823
CA363847654
101 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA3782652
rs747290823
101 Y>S No ClinGen
ExAC
TOPMed
gnomAD
rs778764027
CA3782651
102 V>E No ClinGen
ExAC
gnomAD
rs1361724109
CA363847568
110 H>Y No ClinGen
gnomAD
rs939724253
CA137445708
113 M>I No ClinGen
gnomAD
CA363847532
rs1336473287
115 P>S No ClinGen
gnomAD
rs1561911231
CA363847526
116 T>S No ClinGen
Ensembl
CA363847514
rs1410893491
118 G>R No ClinGen
gnomAD
CA3782630
rs373579558
119 T>A No ClinGen
ESP
ExAC
gnomAD
rs368915787
CA3782629
119 T>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3782627
rs745854778
120 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA363847470
rs1242746186
125 K>R No ClinGen
TOPMed
CA363847462
rs1410145917
126 V>A No ClinGen
gnomAD
rs369569015
CA3782624
127 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs753018828 135 Y>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA363847269
rs1390202425
136 A>T No ClinGen
TOPMed
gnomAD
rs200017678
CA363859251
139 I>L No ClinGen
gnomAD
rs200017678
CA137476745
139 I>V No ClinGen
gnomAD
CA3782599
rs765965617
140 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1466405250
CA363859236
141 Q>R No ClinGen
gnomAD
rs1391140268
CA363859217
144 G>S No ClinGen
TOPMed
CA3782596
rs750479815
146 I>M No ClinGen
ExAC
gnomAD
rs756148781
CA3782597
146 I>T No ClinGen
ExAC
gnomAD
CA137476701
rs868156516
147 G>V No ClinGen
Ensembl
CA3782594
rs761932454
150 R>* No ClinGen
ExAC
gnomAD
CA363859155
COSM1754773
rs1246778699
COSM1754774
150 R>Q Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA363859122
rs1205934617
153 S>G No ClinGen
gnomAD
CA363859096
rs1230629012
155 R>W No ClinGen
TOPMed
gnomAD
rs776647779
CA3782590
159 N>S No ClinGen
ExAC
gnomAD
rs747325086
CA137476634
163 T>A No ClinGen
Ensembl
CA137476632
rs951989042
164 V>A No ClinGen
Ensembl
CA363858990
rs1317129316
164 V>M No ClinGen
gnomAD
rs373286947
CA3782586
165 T>I No ClinGen
ESP
ExAC
gnomAD
CA363858962
rs1561909170
166 R>P No ClinGen
Ensembl
rs1302410389
CA363858967
166 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA363858959
rs1464725459
167 G>S No ClinGen
gnomAD
rs747775404
CA3782585
168 S>I No ClinGen
ExAC
TOPMed
gnomAD
rs778556603
CA3782584
169 M>T No ClinGen
ExAC
gnomAD
rs768969012
CA3782583
170 K>R No ClinGen
ExAC
gnomAD
CA363858830
rs1325426533
172 V>F No ClinGen
TOPMed
gnomAD
CA363858799
rs1291393810
174 P>L No ClinGen
gnomAD
CA3782562
rs371851816
179 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs199823895
CA137476323
183 N>D No ClinGen
1000Genomes
rs907185288
CA137476321
183 N>S No ClinGen
Ensembl
CA3782559
rs781739203
185 D>V No ClinGen
ExAC
gnomAD
rs1289157680
CA363858096
186 D>V No ClinGen
gnomAD
rs757343087
CA3782558
187 M>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 198 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1371746231
CA363857762
199 S>T No ClinGen
TOPMed
CA363857700
rs1386234202
203 M>T No ClinGen
TOPMed
rs1320277777
CA363857676
204 M>I No ClinGen
gnomAD
rs748267263
CA3782536
207 V>A No ClinGen
ExAC
gnomAD
CA3782535
rs779224965
209 R>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 209 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1477375067
CA363857588
210 M>V No ClinGen
gnomAD
rs61753799
CA3782533
213 H>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA137476015
rs17854048
214 P>R No ClinGen
Ensembl
rs1225945406
CA363857493
216 H>Q No ClinGen
TOPMed
CA3782503
rs764720910
218 I>T No ClinGen
ExAC
gnomAD
rs759195401
CA3782502
220 M>I No ClinGen
ExAC
gnomAD
CA363857309
rs1414503487
220 M>R No ClinGen
gnomAD
rs753484837
CA3782501
COSM1078591
221 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA363857297
rs1190642466
221 R>H No ClinGen
TOPMed
gnomAD
CA363857301
rs753484837
221 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA137475554
rs756871835
223 M>T No ClinGen
Ensembl
CA363857167
rs750263128
229 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs750263128
CA3782500
229 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA363857152
rs1561908111
230 E>V No ClinGen
Ensembl
CA363857143
rs1184627045
231 A>S No ClinGen
gnomAD
rs761151722
CA3782499
231 A>V No ClinGen
ExAC
gnomAD
CA363857130
rs1251164305
232 K>R No ClinGen
gnomAD
CA363857109
rs1324005791
234 S>G No ClinGen
gnomAD
CA3782498
rs773786429
234 S>T No ClinGen
ExAC
gnomAD
CA363856400
rs1302494983
236 V>M No ClinGen
TOPMed
rs1368682737
CA363856357
240 I>F No ClinGen
TOPMed
rs771813210
CA3782471
240 I>T No ClinGen
ExAC
gnomAD
CA363856332
rs1236454099
242 K>N No ClinGen
TOPMed
CA363856300
rs1461907588
245 K>E No ClinGen
gnomAD
CA363856295
rs1275397338
245 K>R No ClinGen
TOPMed
rs748071779
CA363856276
246 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA137474256
rs1015670965
250 L>V No ClinGen
Ensembl
TCGA novel
CA363856243
rs1193586456
252 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
TOPMed
NCI-TCGA
rs183558462
CA3782467
254 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs113503273
CA137472584
255 G>E No ClinGen
Ensembl
rs1019030589
CA137472581
258 P>R No ClinGen
TOPMed
rs1008940210
CA137472571
259 H>Y No ClinGen
TOPMed
rs1347231071
CA363856161
263 D>N No ClinGen
TOPMed
rs1269300713
CA363856154
264 V>M No ClinGen
gnomAD
rs1210361175
CA363856113
269 G>D No ClinGen
gnomAD
rs1468028451
CA363856096
272 L>M No ClinGen
gnomAD
rs1468028451
CA363856095
272 L>V No ClinGen
gnomAD
CA3782458
rs775547171
278 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA3782457
rs765344390
286 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA363855988
rs1334060865
288 D>N No ClinGen
TOPMed
gnomAD
CA363855979
rs1216927614
289 T>A No ClinGen
TOPMed
rs907261828
CA137472549
290 P>T No ClinGen
Ensembl
rs776741124
CA3782455
291 G>A No ClinGen
ExAC
TOPMed
gnomAD
rs532519263
CA137472545
291 G>R No ClinGen
1000Genomes
rs776741124
CA363855966
291 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs1459196787
CA363855951
294 G>E No ClinGen
TOPMed
gnomAD
rs1459196787
CA363855949
294 G>V No ClinGen
TOPMed
gnomAD
rs1388848981
CA363855944
295 N>S No ClinGen
TOPMed
gnomAD
rs1468109133
CA363855938
296 D>H No ClinGen
TOPMed
gnomAD
rs1468109133
CA363855939
296 D>N No ClinGen
TOPMed
gnomAD
rs1378850171
CA363855896
302 Q>* No ClinGen
gnomAD
rs1175666074
CA363855891
302 Q>H No ClinGen
TOPMed
CA363855559
rs1433585544
306 A>V No ClinGen
gnomAD
rs1449784347
CA363855539
309 I>V No ClinGen
TOPMed
gnomAD
rs144365701
CA3782441
310 R>Q Variant assessed as Somatic; 4.646e-05 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1241291798
CA363855528
310 R>W No ClinGen
gnomAD
CA363855504
rs1445462124
312 Y>C No ClinGen
gnomAD
CA363855479
rs1178219758
314 K>N No ClinGen
gnomAD
rs1347277457
CA363855461
316 V>A No ClinGen
gnomAD
CA363855466
rs531393329
316 V>L No ClinGen
1000Genomes
ExAC
gnomAD
CA3782439
rs531393329
316 V>M No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 317 M>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA137471746
rs1013286971
317 M>T No ClinGen
gnomAD
rs759644173
CA3782438
317 M>V No ClinGen
ExAC
gnomAD
CA3782413
rs775499566
323 M>I No ClinGen
ExAC
gnomAD
rs1164042591
CA363855347
324 L>P No ClinGen
gnomAD
rs769865009
CA3782412
325 T>S No ClinGen
ExAC
gnomAD
TCGA novel 328 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 328 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363855270
rs1184379216
333 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3782410
rs775977317
334 L>F No ClinGen
ExAC
gnomAD
CA363855240
rs1203051923
335 M>I No ClinGen
gnomAD
CA3782409
rs770528051
335 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA363855178
rs1393026945
341 G>R No ClinGen
gnomAD
CA363855098
rs745972175
348 P>A No ClinGen
ExAC
gnomAD
TCGA novel 348 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs745972175
COSM1078589
CA3782378
348 P>T endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA363855092
rs1187516994
349 Y>H No ClinGen
gnomAD
rs781477169
CA363855078
351 P>S No ClinGen
ExAC
gnomAD
CA3782377
rs781477169
351 P>T No ClinGen
ExAC
gnomAD
rs773269714
CA3782376
352 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA3782375
rs751880012
357 I>V No ClinGen
ExAC
gnomAD
TCGA novel 358 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA137471442
rs940447490
361 K>N No ClinGen
TOPMed
CA3782373
rs754837928
364 S>N No ClinGen
ExAC
gnomAD
rs1231975689
CA363854954
364 S>R No ClinGen
gnomAD
CA3782335
rs779874269
367 G>R No ClinGen
ExAC
gnomAD
TCGA novel 367 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755922640
CA3782334
369 L>R No ClinGen
ExAC
gnomAD
COSM269627
CA363854321
rs1261354210
371 R>* Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA363854319
COSM1078588
rs1476429990
371 R>Q Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA137471009
rs988363803
372 G>D No ClinGen
Ensembl
TCGA novel 373 S>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA363854309
rs1238482176
373 S>Y No ClinGen
gnomAD
TCGA novel 375 L>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1189232626
CA363854286
376 L>V No ClinGen
TOPMed
COSM1286295
rs750316963
CA3782333
377 F>L Variant assessed as Somatic; 0.0 impact. autonomic_ganglia [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
COSM1286295
rs1334453699
CA363854278
377 F>L autonomic_ganglia [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA363854269
COSM245788
rs1561902003
378 R>C prostate [Cosmic] No ClinGen
cosmic curated
Ensembl
CA137471005
rs199805585
379 R>G No ClinGen
gnomAD
CA137471000
rs201349110
379 R>Q No ClinGen
TOPMed
gnomAD
rs751065380
CA3782330
380 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA363854245
rs1451038510
381 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs763576695
CA3782329
384 S>P No ClinGen
ExAC
rs1250903629
CA363854182
389 E>Q No ClinGen
TOPMed
gnomAD
CA3782325
rs759984168
390 E>Y No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with Q9NZJ7

9 regional properties for Q9NZJ7

Type Name Position InterPro Accession
domain Thioredoxin domain 132 - 259 IPR013766-1
domain Thioredoxin domain 268 - 378 IPR013766-2
domain Thioredoxin domain 376 - 504 IPR013766-3
conserved_site Thioredoxin, conserved site 295 - 313 IPR017937-1
conserved_site Thioredoxin, conserved site 416 - 434 IPR017937-2
domain Protein disulfide-isomerase A5, N-terminal TRX-like b domain 26 - 137 IPR041865
domain Protein disulfide-isomerase A5, TRX (a) domain 150 - 254 IPR046374-1
domain Protein disulfide-isomerase A5, TRX (a) domain 275 - 377 IPR046374-2
domain Protein disulfide-isomerase A5, TRX (a) domain 396 - 499 IPR046374-3

Functions

Description
EC Number
Subcellular Localization
  • Mitochondrion outer membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
mitochondrial outer membrane The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

5 GO annotations of biological process

Name Definition
activation of cysteine-type endopeptidase activity involved in apoptotic process Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
neuronal ion channel clustering The process in which voltage-gated ion channels become localized to distinct subcellular domains in the neuron. Specific targeting, clustering, and maintenance of these channels in their respective domains are essential to achieve high conduction velocities of action potential propagation.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
regulation of signal transduction Any process that modulates the frequency, rate or extent of signal transduction.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q791T5 Mtch1 Mitochondrial carrier homolog 1 Mus musculus (Mouse) PR
10 20 30 40 50 60
MGASDPEVAP WARGGAAGMA GAGAGAGARG GAAAGVEARA RDPPPAHRAH PRHPRPAAQP
70 80 90 100 110 120
SARRMDGGSG GLGSGDNAPT TEALFVALGA GVTALSHPLL YVKLLIQVGH EPMPPTLGTN
130 140 150 160 170 180
VLGRKVLYLP SFFTYAKYIV QVDGKIGLFR GLSPRLMSNA LSTVTRGSMK KVFPPDEIEQ
190 200 210 220 230 240
VSNKDDMKTS LKKVVKETSY EMMMQCVSRM LAHPLHVISM RCMVQFVGRE AKYSGVLSSI
250 260 270 280 290 300
GKIFKEEGLL GFFVGLIPHL LGDVVFLWGC NLLAHFINAY LVDDSVSDTP GGLGNDQNPG
310 320 330 340 350 360
SQFSQALAIR SYTKFVMGIA VSMLTYPFLL VGDLMAVNNC GLQAGLPPYS PVFKSWIHCW
370 380
KYLSVQGQLF RGSSLLFRRV SSGSCFALE